Abstract 3013: GSC000829, a novel selective FGFR2/3 inhibitor, displays superior antitumor activity in preclinical FGFR-driven neoplasms models
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Tian Han, Donglin Fu, Tao Cheng, Yuanfeng Xia, Zhilong Hu, Fanglong Yang
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409625284